News & Events

News &

Tarsier Pharma Will Participate at the 17th International Ocular Inflammation Society (IOIS) Congress

September 6-9, 2023

Meet Tarsier Pharma at the 17th International Ocular Inflammation Society (IOIS) Congress, taking place on September 6-9, 2023 in Berlin. 

During this conference:

  • Professor Quan Dong Nguen, Professor Marc de Smet, and Dr. David Chu will host a breakfast event to discuss the latest data from our TRS4Vision phase 3 trial.
  • Daphne Haim-Langford, Tarsier Pharma’s CEO and Chairperson, will be featured as a panelist.
  • Professor Itay Chowers will deliver a presentation based on his article “Suppression of Inflammation for Treating Diabetic Retinopathy and Age-Related Macular Degeneration: Evaluating Dazdotuftide as a Promising Multitarget Therapeutic Candidate.”

Investor Relations Tarsier Pharma
[email protected]

Learn more >>

Scroll to Top